Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/11/2001 | WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
10/11/2001 | WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use |
10/11/2001 | WO2001021765A3 METHOD FOR THE SELECTIVE PROTECTION OF PROLIFERATING NORMAL CELLS AND THE SELECTIVE ERADICATION OF TUMOR CELLS HAVING AN INACTIVE p53 PATHWAY |
10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
10/11/2001 | WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
10/11/2001 | WO2001014572A3 Plant gene expression, controlled by constitutive plant v-atpase promoters |
10/11/2001 | WO2001007470A3 Human nervous system-associated proteins |
10/11/2001 | WO2001004143A3 Prostase vaccine |
10/11/2001 | WO2000065077A8 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
10/11/2001 | WO2000063382A9 Genes and expression products from hematopoietic cells |
10/11/2001 | WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
10/11/2001 | WO2000052135A9 Engineering intracellular sialylation pathways |
10/11/2001 | WO2000050633A9 Method for cloning signal transduction intermediates |
10/11/2001 | WO2000029549A3 Low oxygen culturing of cells |
10/11/2001 | WO2000026240A3 Streptococcal alpha2m-binding protein |
10/11/2001 | US20010029619 Transformation of hereditary material of plants |
10/11/2001 | US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
10/11/2001 | US20010029399 Poly (vinyl alcohol) hydrogel |
10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
10/11/2001 | US20010029246 Antiproliferative agent |
10/11/2001 | US20010029046 A deepithelialized skin diffusion cell system comprising, donor and receptor compartments, and a deepithelized skin sample when placed its deepithelialized side faces into donar compartment and dermal side faces into receptor compartment |
10/11/2001 | US20010029045 Lineage restricted glial precursors from the central nervous system |
10/11/2001 | US20010029034 Hemostasis system-related disorders treatment |
10/11/2001 | US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters |
10/11/2001 | US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof |
10/11/2001 | US20010029012 Immortalizing cells via administering protein derived from Epstein-Barr virus; purine synthesis; telomerases |
10/11/2001 | US20010028882 Anti-cryptosporidium parvum preparations |
10/11/2001 | US20010028879 Inhibition of graft versus host disease |
10/11/2001 | US20010028878 Culture product |
10/11/2001 | EP1144591A3 Low oxygen culturing of cells |
10/11/2001 | DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides |
10/11/2001 | DE10013223A1 In vitro preparation of cartilage and bone tissue, useful for transplantation and for pharmaceutical testing, comprises culturing cells on hydrophobic surfaces to form aggregates |
10/11/2001 | CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
10/11/2001 | CA2405515A1 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w |
10/11/2001 | CA2405473A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
10/11/2001 | CA2405332A1 Fluorescence assay for gamma-secretase activity and inhibitors |
10/11/2001 | CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions |
10/11/2001 | CA2405147A1 Human serine racemase |
10/11/2001 | CA2405063A1 Subtilisin variants |
10/11/2001 | CA2404978A1 Methods, compositions and kits for the detection and monitoring of breast cancer |
10/11/2001 | CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
10/11/2001 | CA2404890A1 Rna sequence-specific mediators of rna interference |
10/11/2001 | CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
10/11/2001 | CA2404541A1 G-protein coupled receptors and nucleic acids encoding same |
10/11/2001 | CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same |
10/11/2001 | CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same |
10/11/2001 | CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
10/11/2001 | CA2404498A1 Sigma binding region of rna polymerase and uses thereof |
10/11/2001 | CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
10/11/2001 | CA2404074A1 Human polynucleotides, polypeptides, and antibodies |
10/11/2001 | CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy |
10/11/2001 | CA2401948A1 Cd20/ige-receptor like molecules and uses thereof |
10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
10/10/2001 | EP1143253A1 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
10/10/2001 | EP1143013A1 Methods and compositions for screening Icrac modulators |
10/10/2001 | EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
10/10/2001 | EP1142996A1 Monoclonal antibody against apolipoprotein a-i |
10/10/2001 | EP1142995A1 Antiuracil monoclonal antibody |
10/10/2001 | EP1142989A2 Chondrocyte cell-lines |
10/10/2001 | EP1142909A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein |
10/10/2001 | EP1142904A1 Sponge protein hydrolysates and methods of producing the same |
10/10/2001 | EP1142581A2 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
10/10/2001 | EP1142473A1 Method of acquiring immunological tolerance |
10/10/2001 | EP1141418A2 Selecting animals for parentally imprinted traits |
10/10/2001 | EP1141407A2 Method of identifying a psychotropic agent using differential gene expression |
10/10/2001 | EP1141389A2 Reagents and methods useful for detecting diseases of the breast |
10/10/2001 | EP1141386A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
10/10/2001 | EP1141383A1 Method and polynucleotides for determining translational efficiency of a codon |
10/10/2001 | EP1141379A1 Screening for inhibitors of terpenoids biosynthesis |
10/10/2001 | EP1141376A1 Peptidoglycan recognition proteins |
10/10/2001 | EP1141366A1 Transfectacons comprising calcium phosphate and a nucleic acid |
10/10/2001 | EP1141361A1 Compositions and methods for packaging of alphavirus vectors |
10/10/2001 | EP1141360A1 Transgenic rodents and rodent cell lines expressing hiv co-receptors |
10/10/2001 | EP1141358A1 ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA |
10/10/2001 | EP1141357A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
10/10/2001 | EP1141356A2 Plant transformation process |
10/10/2001 | EP1141354A1 Plastid transformation of brassica |
10/10/2001 | EP1141352A1 Thioredoxin and grain processing |
10/10/2001 | EP1141350A1 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
10/10/2001 | EP1141347A1 Co-expression of proteins |
10/10/2001 | EP1141346A2 Soybean transformation method |
10/10/2001 | EP1141345A2 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF |
10/10/2001 | EP1141344A2 Herbicide target gene and methods |
10/10/2001 | EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors |
10/10/2001 | EP1141340A1 A method for introducing substances into cells, and use of said method |
10/10/2001 | EP1141336A2 Variants of egiii-like cellulase and compositions thereof |
10/10/2001 | EP1141334A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
10/10/2001 | EP1141332A1 Human cyclic nucleotide pdes |
10/10/2001 | EP1141331A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
10/10/2001 | EP1141326A2 Human akt-3 |
10/10/2001 | EP1141325A1 Ikk3 kinase |
10/10/2001 | EP1141319A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
10/10/2001 | EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
10/10/2001 | EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles |
10/10/2001 | EP1141311A1 Protective antigen of group a streptococci (spa) |
10/10/2001 | EP1141309A1 Streptococcal abc transporter protein |
10/10/2001 | EP1141308A2 Group b streptococcus proteins, and their use |
10/10/2001 | EP1141306A2 Streptococcus antigens |
10/10/2001 | EP1141300A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |